
Zeus Capital Director of Healthcare Research Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss Allergy Therapeutics plc (LON:AGY) Q1: Now, Allergy Therapeutics announced today..
Versarien Plc (LON:VRS) the advanced materials group, CEO Neill Ricketts talks to DirectorsTalk about its agreement with Lansdowne Chemicals. Neill explains the background to the deal, its significance, how they..